Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Carl Zülke
Adjuvant Chemotherapy With Gemcitabine and Long-Term Outcomes Among Patients With Resected Pancreatic Cancer
JAMA - Journal of the American Medical Association
Medicine
Related publications
Practice Patterns and Long-Term Outcomes Among Patients With Pancreatic Giant Cell Tumors
HPB
Hepatology
Gastroenterology
Adjuvant Chemotherapy Versus Chemoradiation for Patients With Resected Pancreatic Adenocarcinoma: A Single-Center Retrospective Study
The Korean Journal of Pancreas and Biliary Tract
Deoxycitidine Kinase Is Associated With Prolonged Survival After Adjuvant Gemcitabine for Resected Pancreatic Adenocarcinoma
Cancer
Cancer Research
Oncology
Timing of Chemotherapy-Induced Neutropenia: The Prognostic Factor in Advanced Pancreatic Cancer Patients Treated With Gemcitabine / Gemcitabine-Based Chemotherapy
Oncotarget
Oncology
Adjuvant Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Pulmonary Metastases From Colorectal Cancer.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Adjuvant Systemic Chemotherapy With or Without Bevacizumab in Patients With Resected Pulmonary Metastases From Colorectal Cancer
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Gemcitabine Combined With Capecitabine Compared to Gemcitabine With or Without Erlotinib as First-Line Chemotherapy in Patients With Advanced Pancreatic Cancer
Cancer Research and Treatment
Cancer Research
Oncology
A Pilot Study- Neoadjuvant Chemotherapy With Gemcitabine and S1 in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Journal of Carcinogenesis & Mutagenesis
Adjuvant Chemotherapy Followed by Concurrent Chemoradiation Is Associated With Improved Survival for Resected Stage I-Ii Pancreatic Cancer
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
